Industry
Medical - Diagnostics & Research
Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Insights
December 08, 2023 | 5:31 pm
Portfolio Pulse from Benzinga Insights
December 06, 2023 | 9:31 pm
Portfolio Pulse from Benzinga Insights
December 06, 2023 | 5:31 pm
Portfolio Pulse from Vandana Singh
December 06, 2023 | 3:13 pm
Portfolio Pulse from Benzinga Newsdesk
December 06, 2023 | 2:17 pm
Portfolio Pulse from Benzinga Newsdesk
December 06, 2023 | 1:34 pm
Portfolio Pulse from Benzinga Insights
November 08, 2023 | 9:55 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.